Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

Stephen J. Proctor, Jennifer Wilkinson, Gail Jones, Gillian C. Watson, Helen H. Lucraft, Tryfonia Mainou-Fowler, Dominic Culligan, Michael J. Galloway, Katrina M. Wood, Richard J. Q. McNally, Peter W. James, John R. Goodlad

Blood (2012) 119 (25): 6005–6015.

https://doi.org/10.1182/blood-2011-12-396556

Published: 2012

Includes: Supplemental data

Journal Articles

Mature MicroRNAs Mir-18, -19a, -19b, -17-5p and -92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia

Rachel E. Culpin, BSc, (Hons), Kim Pearce, PhD, James R. Bailey, MD, PhD, Nicola J. Sunter, PhD, Joanna C. Pointon, PhD, Stephen J. Proctor, MD, David J. Allsup, PhD, MRCP, FRCPath, James M. Allan, PhD, Tryfonia Mainou-Fowler, PhD

Blood (2010) 116 (21): 2727.

https://doi.org/10.1182/blood.V116.21.2727.2727

Published: 2010

Journal Articles

Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England

Anthony V. Moorman, Lucy Chilton, Jennifer Wilkinson, Hannah M. Ensor, Nick Bown, Stephen J. Proctor

Blood (2010) 116 (6): 1012.

https://doi.org/10.1182/blood-2010-04-278895

Published: 2010

Journal Articles

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

Michal Sieniawski, Nithia Angamuthu, Kathryn Boyd, Richard Chasty, John Davies, Peter Forsyth, Fergus Jack, Simon Lyons, Philip Mounter, Paul Revell, Stephen J. Proctor, Anne L. Lennard

Blood (2010) 115 (18): 3664–3670.

https://doi.org/10.1182/blood-2009-07-231324

Published: 2010

Journal Articles

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

Anthony V. Moorman, Lucy Chilton, Jennifer Wilkinson, Hannah M. Ensor, Nick Bown, Stephen J. Proctor

Blood (2010) 115 (2): 206–214.

https://doi.org/10.1182/blood-2009-07-232124

Published: 2010

Journal Articles

Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens.

Michal Sieniawski, James Lennard, Christopher Millar, Simon Lyons, Philip Mounter, Zor Maung, Stephen J. Proctor, Anne L. Lennard

Blood (2009) 114 (22): 1660.

https://doi.org/10.1182/blood.V114.22.1660.1660

Published: 2009

Journal Articles

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Michal Sieniawski, MD, Malcolm Farrow, Xiao Zhao, Jennifer Wilkinson, Tryfonia Mainou-Fowler, Jo White, John MacIntyre, Stephen J. Proctor

Blood (2009) 114 (22): 1666.

https://doi.org/10.1182/blood.V114.22.1666.1666

Published: 2009

Journal Articles

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Michal Sieniawski, Jennifer Wilkinson, Dominic Culligan, John Davies, John Goodlad, Ruth Jarrett, Anne L Lennard, Helen Lucraft, Tryfonia Mainou-Fowler, Pam McKay, Fiona Scott, Sudhir Tauro, Jo White, Stephen J Proctor

Blood (2008) 112 (11): 2604.

https://doi.org/10.1182/blood.V112.11.2604.2604

Published: 2008

Journal Articles

Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches – Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group

Michal Sieniawski, MD, Nithia Angamuthu, Kathryn Boyd, Richard Chasty, John Davies, Paul Revell, Stephen J Proctor, Anne L Lennard

Blood (2008) 112 (11): 578.

https://doi.org/10.1182/blood.V112.11.578.578

Published: 2008

Journal Articles

SGN-30 (Anti-CD30 mAb) Has a Single-Agent Response Rate of 21% in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Blood (2006) 108 (11): 2718.

https://doi.org/10.1182/blood.V108.11.2718.2718

Published: 2006

Journal Articles

The Cost-Effectiveness of Rituximab, Cyclophosphamide, Vincristine and Prednisolone (RCVP) Compared with CVP for the Treatment of Follicular Non-Hodgkin’s Lymphoma (NHL) in the UK.

Gavin Lewis, MSc, Robert E. Marcus, MB, Stephen J. Proctor, FRCP FRCPath, Marlene Gyldmark, James Creeden, MD PhD, Rick Aultman, MSc, Fred Jost, MSc

Blood (2006) 108 (11): 345.

https://doi.org/10.1182/blood.V108.11.345.345

Published: 2006

Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Andres Forero-Torres, MD, Steven H. Bernstein, MD, Ajay K. Gopal, MD, Francine Foss, MD, John P. Leonard, MD, Joseph D. Rosenblatt, MD, Nancy L. Bartlett, MD, Bruce D. Cheson, MD, Elliott Epner, MD, Francisco J. Hernandez-Illizaliturri, MD, Stephen J. Proctor, MD, Pauline Brice, MD, Harve Tilly, MD, Corinne Haioun, MD, Mats Jerkeman, MD, Andre Bosly, MD, Jennie M. Lorenz, Jeremy Barton, MD

Blood (2005) 106 (11): 3356.

https://doi.org/10.1182/blood.V106.11.3356.3356

Published: 2005

Journal Articles

Follicular Lymphoma International Prognostic Index

Blood (2004) 104 (5): 1258–1265.

https://doi.org/10.1182/blood-2003-12-4434

Published: 2004

Journal Articles

Cytokine Gene Polymorphisms Associating With Severe Acute Graft-Versus-Host Disease in HLA-Identical Sibling Transplants

Peter G. Middleton, Penelope R.A. Taylor, Graham Jackson, Stephen J. Proctor, Anne M. Dickinson

Blood (1998) 92 (10): 3943–3948.

https://doi.org/10.1182/blood.V92.10.3943

Published: 1998

NARROW

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

Mature MicroRNAs Mir-18, -19a, -19b, -17-5p and -92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia

Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens.

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

SGN-30 (Anti-CD30 mAb) Has a Single-Agent Response Rate of 21% in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

The Cost-Effectiveness of Rituximab, Cyclophosphamide, Vincristine and Prednisolone (RCVP) Compared with CVP for the Treatment of Follicular Non-Hodgkin’s Lymphoma (NHL) in the UK.

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Follicular Lymphoma International Prognostic Index

Cytokine Gene Polymorphisms Associating With Severe Acute Graft-Versus-Host Disease in HLA-Identical Sibling Transplants

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only